IP Library Granted Patent US 12,435,367
Granted Patent B2
US 12,435,367 · App. 17/505,085 · Granted Oct 7, 2025

Apparatus, system, and method using immiscible-fluid-discrete-volumes

Inventors: Linda G. Lee (Palo Alto, CA); Sam L Woo (Redwood City, VA); Congcong Ma (Foster City, CA); Richard T. Reel (Hayward, CA); Mark F. Oldham (Emerald Hills, CA); David M. Cox (Foster City, CA); Benjamin G. Schroeder (San Mateo, CA); Jon M. Sorenson (Alameda, CA); Willy Wiyatno (Union City, CA)
Assignee: APPLIED BIOSYSTEMS, LLC
C12Q1/6869B01L3/502715B01L3/502784C12Q1/6806C12Q1/6874F15C5/00F16K99/0001F16K99/0011F16K99/0013G01N1/14G01N27/44743G01N27/44769G01N35/08B01J2219/00353B01J2219/0036B01J2219/00364B01J2219/00608B01J2219/0061B01J2219/00612B01J2219/00619B01J2219/00626B01J2219/00637B01J2219/00653B01J2219/00657B01J2219/00659B01L3/0293B01L7/52B01L2200/0673B01L2200/10B01L2300/0864B01L2300/0867B01L2400/0421B01L2400/0487C12Q2535/101F16K2099/0084Y10T137/0318Y10T137/4259Y10T137/85978Y10T137/85986Y10T137/86863Y10T436/2575
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,435,367
App. No.
17/505,085
Granted
Oct 7, 2025
Kind
B2
Abstract

Various embodiments of the teachings relate to a system or method for sample preparation or analysis in biochemical or molecular biology procedures. The sample preparation can involve small volume processed in discrete portions or segments or slugs, herein referred to as discrete volumes. A molecular biology procedure can be nucleic acid analysis. Nucleic acid analysis can be an integrated DNA amplification/DNA sequencing procedure.

Claims (30)

1. A method comprising:

contacting a stream of aqueous sample fluid flowing in a first conduit with a stream of non-aqueous spacing fluid that is immiscible with the aqueous sample fluid to form discrete volumes of the aqueous sample fluid separated from one another by the non-aqueous spacing fluid, wherein the aqueous sample fluid comprises target nucleic acid, and wherein a first plurality of the discrete volumes contains at least one molecule comprising the target nucleic acid and a second plurality of the discrete volumes contains no molecules comprising the target nucleic acid;

amplifying the target nucleic acid in one or more of the first plurality of the discrete volumes to form an amplicon;

after amplifying the target nucleic acid, adding additional spacing fluid between consecutive discrete volumes of one or both of the first plurality of discrete volumes and the second plurality of discrete volumes, so as to adjust or control spacing between the consecutive discrete volumes;

in a second conduit, detecting a fluorescence signal from the amplicon in the one or more of the first plurality of the discrete volumes; and

based on the detecting, discriminating between the one or more of the first plurality of the discrete volumes and the second plurality of the discrete volumes.

2. The method of claim 1 , wherein the contacting comprises continuously flowing at least one of the aqueous sample fluid and the non-aqueous spacing fluid into the first conduit.

3. The method of claim 1 , further comprising separating the second plurality of the discrete volumes from the first plurality of the discrete volumes.

4. The method of claim 1 , wherein less than 37% of the first plurality of the discrete volumes comprise a single molecule comprising the target nucleic acid.

5. The method of claim 4 , wherein 1% or more of the first plurality of the discrete volumes comprise a single molecule comprising the target nucleic acid.

6. The method of claim 4 , wherein 10% or more of the first plurality of discrete volumes comprise a single molecule comprising the target nucleic acid.

7. The method of claim 1 , wherein the discrete volumes comprise droplets of the aqueous sample fluid.

8. The method of claim 1 further comprising:

dispensing the discrete volumes from the first conduit and into one or more containers, wherein the amplifying occurs while the discrete volumes are in the one or more containers.

9. The method of claim 8 , wherein the one or more containers comprise wells of a multi-well plate.

10. The method of claim 8 , wherein at least some of the discrete volumes have a volume that is less than about 50 nanoliters.

11. The method of claim 8 , wherein at least some of the discrete volumes have a volume of between about 1 femtoliter and 1 nanoliter.

12. The method of claim 1 , wherein the first and second conduits are in fluid communication with each other.

13. The method of claim 1 , further comprising sequencing the amplicon.

14. The method of claim 1 , further comprising running the amplicon through a capillary.

15. The method of claim 1 , further comprising running the amplicon through a capillary electrophoretic sequencer.

16. A method comprising:

forming droplets of an aqueous sample fluid separated from one another by a spacing fluid that is immiscible with the aqueous sample fluid, the aqueous sample fluid comprising a polynucleotide comprising a target nucleic acid sequence, wherein a first plurality of droplets contains at least one molecule of the polynucleotide comprising the target nucleic acid sequence per droplet and a second plurality of droplets contains no molecules of the polynucleotide comprising the target nucleic acid sequence;

performing an amplification assay on the polynucleotide in one or more of the first plurality of droplets to form an amplicon;

after performing the amplification assay, adding additional spacing fluid between consecutive aqueous droplets of one or both of the first plurality of aqueous droplets and the second plurality of aqueous droplets, so as to adjust or control the spacing between the consecutive aqueous droplets; and

monitoring for a fluorescence signal from one or more of the first plurality of droplets, the fluorescent signal indicative of a presence of the amplicon.

17. The method of claim 16 , wherein 1% or more of the droplets comprise a single molecule comprising the target nucleic acid sequence.

18. The method of claim 16 , wherein less than 37% of the droplets comprise a single molecule comprising the target nucleic acid sequence.

19. The method of claim 16 , wherein at least some of the droplets have a volume that is less than about 50 nanoliters.

20. The method of claim 16 , further comprising sequencing the amplicon.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 22, 2021
From: LEE, LINDA G.; WOO, SAM L.; MA, CONGCONG; REEL, RICHARD T.; OLDHAM, MARK F.; COX, DAVID M.; SCHROEDER, BENJAMIN; SORENSON, JON; WIYATNO, WILLY
To: APPLERA CORPORATION
Reel/Frame 057878/0434 →
MERGER AND CHANGE OF NAME Recorded Oct 22, 2021
From: APPLERA CORPORATION; APPLIED BIOSYSTEMS, INC.
To: APPLIED BIOSYSTEMS INC.
Reel/Frame 057878/0486 →
MERGER Recorded Oct 22, 2021
From: ATOM AQUISITION CORPORATION
To: APPLIED BIOSYSTEMS, INC.
Reel/Frame 057878/0493 →
MERGER AND CHANGE OF NAME Recorded Oct 22, 2021
From: APPLIED BIOSYSTEMS INC.; ATOM AQUISITION, LLC; APPLIED BIOSYSTEMS, LLC
To: APPLIED BIOSYSTEMS, LLC
Reel/Frame 057878/0499 →
Continuity (8)
Continuation 16054391 · Aug 3, 2018
Division 14925656 · Oct 28, 2015
Division 12557488 · Sep 10, 2009
Continuation 11507735 · Aug 22, 2006
Provisional Application 60818197 · Jun 30, 2006
Provisional Application 60731133 · Oct 28, 2005
Provisional Application 60710167 · Aug 22, 2005
Related Publication 20220033896A1 · Feb 3, 2022
References Cited (105)
US 3640822A · Hrdina · 1972 [cited by applicant]
US 3743103A · Isreeli · 1973 [cited by applicant]
US 3960020A · Gordon et al. · 1976 [cited by applicant]
US 4253846A · Smythe et al. · 1981 [cited by applicant]
US 4271123A · Curry et al. · 1981 [cited by applicant]
US 4528158A · Gilles et al. · 1985 [cited by applicant]
US 4574850A · Davis et al. · 1986 [cited by applicant]
US 4610170A · Ekholm et al. · 1986 [cited by applicant]
US 4908112A · Pace · 1990 [cited by applicant]
US 5092972A · Ghowsi · 1992 [cited by applicant]
US 5134079A · Cusack · 1992 [cited by applicant]
US 5149658A · Cassaday · 1992 [cited by applicant]
US 5645930A · Tsou · 1997 [cited by applicant]
US 5739036A · Parris · 1998 [cited by applicant]
US 5843767A · Beattie et al. · 1998 [cited by applicant]
US 5848107A · Philips · 1998 [cited by applicant]
US 5884649A · Proudman · 1999 [cited by applicant]
US 5942443A · Parce et al. · 1999 [cited by applicant]
US 5961800A · McBride et al. · 1999 [cited by applicant]
US 6057100A · Heyneker · 2000 [cited by applicant]
US 6143496A · Brown et al. · 2000 [cited by applicant]
US 6258324B1 · Yiu · 2001 [cited by applicant]
US 6432814B1 · Steiner et al. · 2002 [cited by applicant]
US 6485905B2 · Hefti · 2002 [cited by applicant]
US 6508273B1 · Van Den Berg · 2003 [cited by applicant]
US 6626416B2 · Sharma et al. · 2003 [cited by applicant]
US 6638760B1 · Chen · 2003 [cited by applicant]
US 6719535B2 · Rakestraw et al. · 2004 [cited by applicant]
US 6814934B1 · Higuchi · 2004 [cited by applicant]
US 6895964B2 · McAuliffe et al. · 2005 [cited by applicant]
US 6908770B1 · McDevitt et al. · 2005 [cited by applicant]
US 7041481B2 · Anderson · 2006 [cited by applicant]
US 7459315B2 · Brown · 2008 [cited by applicant]
US RE41780E · Anderson et al. · 2010 [cited by applicant]
US 7955864B2 · Cox et al. · 2011 [cited by applicant]
US 8592221B2 · Fraden et al. · 2013 [cited by applicant]
US 9127310B2 · Larson et al. · 2015 [cited by applicant]
US 9194772B2 · Lee · 2015 [cited by examiner]
US 9441266B2 · Larson et al. · 2016 [cited by applicant]
US 10041113B2 · Lee · 2018 [cited by examiner]
US 10286396B2 · Fraden et al. · 2019 [cited by applicant]
US 11162137B2 · Lee · 2021 [cited by examiner]
US 20010049148A1 · Wolk et al. · 2001 [cited by applicant]
US 20020159919A1 · Churchill · 2002 [cited by applicant]
US 20020166582A1 · O'Connor et al. · 2002 [cited by applicant]
US 20030006140A1 · Vacca et al. · 2003 [cited by applicant]
US 20030013200A1 · Pai et al. · 2003 [cited by applicant]
US 20030138819A1 · Gong et al. · 2003 [cited by applicant]
US 20030145894A1 · Burns · 2003 [cited by applicant]
US 20030162213A1 · Fuller et al. · 2003 [cited by applicant]
US 20030194709A1 · Yang · 2003 [cited by applicant]
US 20030199081A1 · Wilding et al. · 2003 [cited by applicant]
US 20030213905A1 · Lennon et al. · 2003 [cited by applicant]
US 20040014239A1 · Wolk et al. · 2004 [cited by applicant]
US 20040058450A1 · Pamula et al. · 2004 [cited by applicant]
US 20040171055A1 · Brown · 2004 [cited by applicant]
US 20040180346A1 · Anderson et al. · 2004 [cited by applicant]
US 20040185484A1 · Costa et al. · 2004 [cited by applicant]
US 20040188254A1 · Spaid · 2004 [cited by applicant]
US 20040194562A1 · Brockman et al. · 2004 [cited by applicant]
US 20040234966A1 · Bryning et al. · 2004 [cited by applicant]
US 20040241721A1 · Gjerde et al. · 2004 [cited by applicant]
US 20040248144A1 · Mir · 2004 [cited by applicant]
US 20050130173A1 · Leamon et al. · 2005 [cited by applicant]
US 20050172476A1 · Stone et al. · 2005 [cited by applicant]
US 20050223822A1 · Ozbal · 2005 [cited by applicant]
US 20050227264A1 · Nobile · 2005 [cited by applicant]
US 20060003439A1 · Ismagilov · 2006 [cited by applicant]
US 20060037657A1 · Shibata et al. · 2006 [cited by applicant]
US 20060056904A1 · Haselton et al. · 2006 [cited by applicant]
US 20060163385A1 · Link et al. · 2006 [cited by applicant]
US 20070014695A1 · Yue et al. · 2007 [cited by applicant]
US 20070039866A1 · Schroeder · 2007 [cited by applicant]
US 20070054266A1 · Sato et al. · 2007 [cited by applicant]
US 20070068573A1 · Cox · 2007 [cited by applicant]
US 20070122314A1 · Strand et al. · 2007 [cited by applicant]
US 20070141593A1 · Lee · 2007 [cited by applicant]
US 20070195127A1 · Ahn · 2007 [cited by applicant]
US 20080023330A1 · Viovy et al. · 2008 [cited by applicant]
US 20100209916A1 · Zon · 2010 [cited by applicant]
US 20110171748A1 · Cox et al. · 2011 [cited by applicant]
WO 2004002627 · 2004 [cited by applicant]
WO 2005021151 · 2005 [cited by applicant]
WO 2005073410 · 2005 [cited by applicant]
WO 2005080606A1 · 2005 [cited by applicant]
International Preliminary Report on Patentability for Appl. No. PCT/US2006/032602 dated Feb. 26, 2008. [cited by applicant]
Extended European Search Report for Appl. No. 06802016.3 mailed Nov. 3, 2010. [cited by applicant]
Ajdari, et al., “Droplet Control for Microfiuidics”, [cited by applicant]
Anderson, et al., [cited by applicant]
Auroux, Pierre-Alain et al., “Miniaturised nucleic acid analysis”, [cited by applicant]
Burns, et al., “Microfabricated Structures for Integrated DNA Analysis”, [cited by applicant]
Chiou, J. et al., “A Closed-Cycle Capillary Polymerase Chain Reaction Machine”, [cited by applicant]
Curcio, Mario et al., “Continuous segmented-Flow Polymerase Chain Reaction for High-Throughput Miniaturized DNA Amplification”, [cited by applicant]
Dittrich et al., Anal Bioanal. Chem. 382:1771-1782, (Jun. 2005). [cited by applicant]
Hashimoto, et al., “On-line integration of PCR and cycle sequencing in capillaries: from human genomic DNA directly to called bases”, [cited by applicant]
Miller, et al., [cited by applicant]
Nia and Zare, Annu. Rev. Biomol. Struct. 26:567-596 (Year: 1997). [cited by applicant]
Obeid, P. J. et al., “Microfabricated systems for nucleic acid analysis”, [cited by applicant]
PCT/US2006/032640, International Search Report dated Jan. 17, 2008. [cited by applicant]
PCT/US2006/032640, Written Opinion of International Searching Authority dated Jan. 17, 2008. [cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US2006/032602 dated Aug. 27, 2007. [cited by applicant]
Schneegass, et al., “Miniaturized flow-through PCR with different template types in a silicon chip thermocycler”, [cited by applicant]
Song et al., Angrew Chem. Int. Ed. 43:7, 768-772 (Year: 2003). [cited by applicant]
Thorsen, et al., “Dynamic Pattern Formation in a Vesicle-Generating Microfiuidic Device”, [cited by applicant]
Waters, L. C. et al., “Microchip Device for Cell Lysis, Multiplex PCR Amplification, and Electrophoretic Sizing”, Analytical Chemistry, vol. 70, No. 1, American Chemical Society, Columbus, US,, 1998, 158-162. [cited by applicant]